Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives
Giovanni Martinotti, Rita Santacroce, Mauro Pettorruso, Chiara Montemitro, Maria Spanò, Marco Lorusso, Massimo Di Giannantonio, Arturo G Lerner
Brain Sciences March 16, 2018 DOI: 10.3390/brainsci8030047 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Systematic review Peer reviewed |
|---|---|
| Keywords | Hallucinogen Etiology Perception Clinical psychology |
| Citations | 171 |
| Key findings | HPPD is a rare disorder with limited understanding and treatment options, often linked to hallucinogenic drugs and prior psychological issues. |
Abstract
Hallucinogen Persisting Perception Disorder (HPPD) is a rare, and therefore, poorly understood condition linked to hallucinogenic drugs consumption. The prevalence of this disorder is low; the condition is more often diagnosed in individuals with a history of previous psychological issues or substance misuse, but it can arise in anyone, even after a single exposure to triggering drugs. The aims of the present study are to review all the original studies about HPPD in order to evaluate the following: (1) the possible suggested etiologies; (2) the possible hallucinogens involved in HPPD induction; (3) the clinical features of both HPPD I and II; (4) the possible psychiatric comorbidities; and (5) the available and potential therapeutic strategies. We searched PubMed to identify original studies about psychedelics and Hallucinogen Persisting Perception Disorder (HPPD). Our research yielded a total of 45 papers, which have been analyzed and tabled to provide readers with the most updated and comprehensive literature review about the clinical features and treatment options for HPPD.
Citations in the library
Cited by 95
- Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms Pharmacological Reviews December 16, 2020
- Microdosing psychedelics: personality, mental health, and creativity differences in microdosers Psychopharmacology January 2, 2019
- New/emerging psychoactive substances and associated psychopathological consequences Psychological Medicine July 22, 2019
- Case analysis of long-term negative psychological responses to psychedelics Scientific Reports September 25, 2023
- Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential? Frontiers in Psychiatry July 19, 2021
and 90 more in the library
Cites 29
- Novel psychoactive substances of interest for psychiatry World Psychiatry February 1, 2016
- Amanita muscaria: chemistry, biology, toxicology, and ethnomycology. Mycological research February 1, 2003
- Clinical applications of hallucinogens: A review. Experimental and Clinical Psychopharmacology August 1, 2016
- The psychopharmacology of hallucinogens. Neuropsychopharmacology April 1, 1996
- Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. Journal of Pharmacology and Experimental Therapeutics September 1, 1988
and 24 more in the library